MeSH term
Frequency | Condition_Probility | Animals | 70 | 0.0 |
Humans | 84 | 0.0 |
Blotting, Western | 3 | 0.0 |
COS Cells | 18 | 0.0 |
Cell Line | 36 | 0.0 |
DNA-Binding Proteins/genetics/metabolism | 7 | 1.0 |
Gene Expression Regulation/drug effects | 4 | 0.0 |
*Intracellular Signaling Peptides and Proteins | 3 | 0.0 |
Mutation | 8 | 0.0 |
Precipitin Tests | 8 | 0.0 |
Protein-Serine-Threonine Kinases/genetics/metabolism | 5 | 4.0 |
Receptors, Growth Factor/genetics/metabolism | 4 | 19.0 |
*Signal Transduction | 10 | 0.0 |
Trans-Activators/genetics/metabolism | 5 | 2.0 |
Transcription, Genetic | 12 | 0.0 |
*Transforming Growth Factor beta | 16 | 10.0 |
Tumor Cells, Cultured | 12 | 0.0 |
Two-Hybrid System Techniques | 7 | 0.0 |
Bone Morphogenetic Proteins/pharmacology | 4 | 12.0 |
Cell Differentiation | 8 | 0.0 |
DNA-Binding Proteins/*physiology | 5 | 0.0 |
Mice | 30 | 0.0 |
Research Support, Non-U.S. Gov't | 69 | 0.0 |
Trans-Activators/*physiology | 5 | 1.0 |
Bone Morphogenetic Proteins/genetics/*metabolism | 2 | 11.0 |
Cattle | 2 | 0.0 |
DNA-Binding Proteins/genetics/*metabolism | 6 | 0.0 |
Mutagenesis, Site-Directed | 4 | 0.0 |
Phosphorylation/drug effects | 2 | 0.0 |
Research Support, U.S. Gov't, P.H.S. | 36 | 0.0 |
Trans-Activators/genetics/*metabolism | 6 | 1.0 |
Transcription Factors/genetics/metabolism | 3 | 0.0 |
Transfection | 20 | 0.0 |
Cells, Cultured | 14 | 0.0 |
DNA-Binding Proteins/genetics | 2 | 0.0 |
Female | 16 | 0.0 |
Granulosa Cells/*metabolism | 2 | 5.0 |
Receptors, Cell Surface/metabolism | 5 | 1.0 |
*Receptors, Growth Factor | 7 | 21.0 |
Signal Transduction/*physiology | 16 | 1.0 |
Trans-Activators/genetics | 3 | 1.0 |
Osteoblasts/cytology/drug effects/*metabolism | 2 | 16.0 |
Receptors, Transforming Growth Factor beta/genetics/metabolism | 4 | 26.0 |
Signal Transduction | 18 | 0.0 |
ras Proteins/*metabolism | 3 | 1.0 |
Blotting, Northern | 5 | 0.0 |
Bone Morphogenetic Proteins/*pharmacology | 6 | 11.0 |
Breast Neoplasms/*metabolism | 3 | 1.0 |
Cell Division/drug effects | 4 | 0.0 |
RNA, Messenger/analysis | 2 | 0.0 |
Trans-Activators/physiology | 2 | 1.0 |
Bone Morphogenetic Proteins/metabolism/*physiology | 2 | 66.0 |
Cell Differentiation/physiology | 3 | 0.0 |
DNA-Binding Proteins/metabolism | 11 | 0.0 |
Immunohistochemistry | 5 | 0.0 |
Phosphorylation | 21 | 0.0 |
Protein Binding | 18 | 0.0 |
Signal Transduction/physiology | 7 | 0.0 |
Trans-Activators/metabolism | 17 | 1.0 |
Binding Sites | 12 | 0.0 |
Cloning, Molecular | 11 | 0.0 |
DNA-Binding Proteins/chemistry/*genetics/*metabolism | 2 | 5.0 |
Genes, Reporter | 9 | 0.0 |
Helix-Loop-Helix Motifs | 2 | 0.0 |
Luciferases/genetics | 3 | 0.0 |
Promoter Regions (Genetics) | 7 | 0.0 |
Recombinant Proteins/metabolism | 3 | 0.0 |
*Repressor Proteins | 7 | 0.0 |
*Trans-Activation (Genetics) | 4 | 0.0 |
Trans-Activators/chemistry/*metabolism | 4 | 6.0 |
Transcription Factors/*genetics | 2 | 0.0 |
Bone Morphogenetic Proteins/*metabolism/pharmacology | 3 | 50.0 |
Phosphoproteins/genetics | 2 | 1.0 |
Activin Receptors, Type I/metabolism | 2 | 11.0 |
DNA-Binding Proteins/*metabolism | 16 | 0.0 |
Trans-Activators/*metabolism | 15 | 1.0 |
Ubiquitin/metabolism | 3 | 1.0 |
Base Sequence | 5 | 0.0 |
Molecular Sequence Data | 25 | 0.0 |
Plasmids/metabolism | 7 | 0.0 |
Protein Structure, Tertiary | 11 | 0.0 |
Rats | 8 | 0.0 |
Active Transport, Cell Nucleus | 2 | 0.0 |
Amino Acid Sequence | 23 | 0.0 |
Cell Nucleus/*metabolism | 3 | 0.0 |
Green Fluorescent Proteins | 3 | 0.0 |
Ligands | 8 | 0.0 |
Luciferases/metabolism | 7 | 1.0 |
Luminescent Proteins/metabolism | 3 | 0.0 |
Microscopy, Fluorescence | 3 | 0.0 |
Sequence Homology, Amino Acid | 13 | 0.0 |
Trans-Activation (Genetics) | 4 | 0.0 |
Dose-Response Relationship, Drug | 3 | 0.0 |
Fibroblasts/*metabolism | 2 | 1.0 |
Genes, Dominant | 2 | 0.0 |
Genetic Vectors | 4 | 0.0 |
Immunoblotting | 4 | 0.0 |
Nuclear Proteins/metabolism | 2 | 0.0 |
Transforming Growth Factor beta/*metabolism | 8 | 3.0 |
*Promoter Regions (Genetics) | 2 | 0.0 |
Response Elements | 2 | 0.0 |
Enzyme Activation | 3 | 0.0 |
Transforming Growth Factor beta/*physiology | 3 | 2.0 |
Enzyme Inhibitors/pharmacology | 2 | 0.0 |
Mitogen-Activated Protein Kinases/metabolism | 3 | 0.0 |
Proto-Oncogene Proteins c-bcl-2/metabolism | 3 | 0.0 |
Recombinant Proteins/pharmacology | 2 | 0.0 |
Signal Transduction/drug effects/*physiology | 2 | 0.0 |
Skull/cytology | 2 | 28.0 |
Transcription Factors/genetics | 2 | 0.0 |
Transforming Growth Factor beta/pharmacology | 4 | 1.0 |
Mink | 4 | 6.0 |
Transforming Growth Factor beta/metabolism | 6 | 3.0 |
Bone Morphogenetic Proteins/metabolism | 4 | 7.0 |
Gene Expression/physiology | 2 | 0.0 |
Transcription Factors/*metabolism | 4 | 0.0 |
Bone Morphogenetic Proteins/*metabolism | 13 | 31.0 |
Cell Division/physiology | 2 | 0.0 |
Mice, Inbred C57BL | 2 | 0.0 |
Mice, Knockout | 2 | 0.0 |
Phosphoproteins/metabolism | 2 | 0.0 |
Transcription, Genetic/physiology | 2 | 1.0 |
Oocytes/physiology | 2 | 1.0 |
Sequence Alignment | 7 | 0.0 |
Substrate Specificity | 2 | 0.0 |
Ubiquitin-Protein Ligases | 2 | 0.0 |
Xenopus laevis | 4 | 0.0 |
*Gene Expression Regulation | 2 | 0.0 |
Glutathione Transferase/metabolism | 5 | 0.0 |
Models, Genetic | 3 | 0.0 |
Recombinant Fusion Proteins/metabolism | 8 | 0.0 |
*Transcription, Genetic | 2 | 0.0 |
Research Support, U.S. Gov't, Non-P.H.S. | 3 | 0.0 |
*Xenopus Proteins | 8 | 2.0 |
Comparative Study | 3 | 0.0 |
DNA, Complementary/chemistry/genetics | 2 | 0.0 |
Male | 6 | 0.0 |
Sequence Analysis, DNA | 2 | 0.0 |
Gene Targeting | 2 | 0.0 |
DNA Primers | 2 | 0.0 |
Phenotype | 4 | 0.0 |
Protein Conformation | 3 | 0.0 |
Transcription Factors/*physiology | 2 | 0.0 |
Trans-Activators/*antagonists & inhibitors/physiology | 2 | 33.0 |
CHO Cells | 2 | 0.0 |
*DNA-Binding Proteins | 3 | 0.0 |
Hamsters | 3 | 0.0 |
Proteins/*metabolism | 2 | 0.0 |
Receptors, Cell Surface/physiology | 2 | 1.0 |
Reverse Transcriptase Polymerase Chain Reaction | 6 | 0.0 |
Signal Transduction/drug effects | 4 | 0.0 |
*Trans-Activators | 5 | 0.0 |
*Mitogen-Activated Protein Kinase Kinases | 2 | 2.0 |
Protein-Serine-Threonine Kinases/metabolism | 6 | 0.0 |
DNA-Binding Proteins/*chemistry/*metabolism | 2 | 3.0 |
Trans-Activators/*chemistry/*metabolism | 2 | 11.0 |
*Nuclear Proteins | 2 | 0.0 |
Rabbits | 2 | 0.0 |
Transforming Growth Factor beta/physiology | 6 | 6.0 |
Adolescent | 2 | 0.0 |
Activins | 5 | 6.0 |
Body Patterning | 2 | 3.0 |
DNA-Binding Proteins/chemistry/*metabolism | 2 | 1.0 |
Gene Expression Regulation, Developmental | 3 | 0.0 |
Nervous System/embryology | 3 | 9.0 |
Adult | 4 | 0.0 |
Aged | 3 | 0.0 |
Aged, 80 and over | 2 | 0.0 |
DNA-Binding Proteins/biosynthesis | 2 | 2.0 |
In Situ Hybridization | 5 | 0.0 |
Middle Aged | 3 | 0.0 |
Trans-Activators/biosynthesis | 2 | 5.0 |
Drosophila | 3 | 0.0 |
Models, Molecular | 3 | 0.0 |
*Embryonic Induction | 2 | 9.0 |
DNA/biosynthesis | 2 | 0.0 |
Transforming Growth Factor beta/*pharmacology | 6 | 1.0 |
Receptors, Growth Factor/metabolism | 6 | 5.0 |
Gene Expression | 2 | 0.0 |
Inhibins/pharmacology | 2 | 11.0 |
Bone Morphogenetic Proteins/*physiology | 3 | 13.0 |
Transcription Factors/metabolism | 4 | 0.0 |
Mice, Inbred C3H | 2 | 0.0 |
Xenopus | 5 | 0.0 |
Cell Nucleus/metabolism | 6 | 0.0 |
DNA/metabolism | 3 | 0.0 |
Gene Deletion | 2 | 0.0 |
*Genes, Tumor Suppressor | 3 | 0.0 |
Recombinant Fusion Proteins/genetics/metabolism | 2 | 0.0 |
Receptors, Transforming Growth Factor beta/metabolism | 2 | 4.0 |
Transforming Growth Factor beta/antagonists & inhibitors/*metabolism | 3 | 30.0 |
Alkaline Phosphatase/metabolism | 3 | 2.0 |
Gene Expression/drug effects | 2 | 0.0 |
Mesoderm/physiology | 2 | 5.0 |
Polymerase Chain Reaction | 2 | 0.0 |
Embryo, Nonmammalian/metabolism | 2 | 5.0 |
Rats, Sprague-Dawley | 3 | 0.0 |
Cell Differentiation/*physiology | 4 | 1.0 |
Adenoviridae/genetics | 2 | 0.0 |
Mice, Nude | 3 | 0.0 |
RNA/metabolism | 2 | 0.0 |
p38 Mitogen-Activated Protein Kinases | 2 | 0.0 |
Gene Expression Regulation | 3 | 0.0 |
DNA-Binding Proteins/chemistry/genetics/*metabolism | 2 | 1.0 |
In Vitro | 2 | 0.0 |
Nuclear Proteins/genetics/*metabolism | 2 | 0.0 |
Trans-Activators/chemistry/genetics/*metabolism | 2 | 2.0 |
Histone Deacetylases/metabolism | 2 | 2.0 |
Proto-Oncogene Proteins/*metabolism | 3 | 0.0 |
Activin Receptors, Type I/genetics/metabolism | 2 | 28.0 |
Activins/*pharmacology | 2 | 33.0 |
Cytoplasm/metabolism | 2 | 0.0 |
Immunoenzyme Techniques | 2 | 0.0 |
RNA, Messenger/metabolism | 2 | 0.0 |
Macromolecular Substances | 2 | 0.0 |
Models, Biological | 2 | 0.0 |
Signal Transduction/drug effects/physiology | 2 | 0.0 |
Time Factors | 3 | 0.0 |
Cell Division | 4 | 0.0 |
Chromatin/metabolism | 2 | 0.0 |
Amino Acid Motifs | 3 | 0.0 |
Bone Morphogenetic Proteins/antagonists & inhibitors/*metabolism | 2 | 40.0 |
Cell Differentiation/drug effects/physiology | 2 | 2.0 |
